A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

Despite the potential benefits of early detection and increasing treatment options for Alzheimer's disease and related ...

On Join Dementia Research's tenth anniversary we look at what taking part in a study into sleep, Down's syndrome and dementia ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

Alzheimer’s disease is one of the toughest medical issues that disrupts a person's daily life. Thankfully, medical advances ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...